Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy

ConclusionsHR-positive young breast cancer patients have a poorer survival compared with older patients, even with more frequent chemotherapy, but more recent use of tamoxifen and ovarian suppression might improve this outcome in these patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research